COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it will report its financial results for second quarter ended June 30, 2015, on Wednesday, August 5, 2015. Lode Debrabandere, Ph.D., President and Chief Executive Officer, and Philip R. Jacoby, Jr., Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Wednesday, August 5, 2015, at 9:00 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
